RKDA — Arcadia Biosciences Inc
NASDAQ · Consumer Defensive · Packaged Foods
$0.48
-$0.02 (-4.51%)
Arcadia Biosciences Inc (RKDA) is a packaged foods company listed on NASDAQ. It is led by Thomas J. Schaefer C.F.A., based in 5956 Sherry Lane, Dallas, TX, United States, 75225, with about 8 employees. Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Latest reported RKDA revenue for 2025-09-30 was $1.3M. Net income was $856.0K. Revenue was down 10.5% from 2025-06-30 to 2025-09-30. RKDA currently screens at market cap $1.7M.
Use this RKDA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RKDA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RKDA SEC filings page. Lician reads the product cache first so this HTML stays unique to Arcadia Biosciences Inc even when a live quote feed is slow.
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
RKDA Key Statistics
Market Cap
$1.68M
Volume
30,760
Previous Close
$0.48
Day Range
$0.46 – $0.48
P/B Ratio
0.61
EPS
-$5.17
Revenue
$5.04M
Net Income
-$7.04M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+13.3%
Profit Margin
-139.5%
Employees
8
RKDA Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $5.04M | $4.45M | $7.42M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$7.04M | -$13.99M | -$15.61M |
| EPS (Diluted) | -$5.17 | -$11.29 | -$25.65 |
Total Assets
$13.52M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$4.24M
Operating Cash Flow
-$9.63M
Free Cash Flow
$0.00
Arcadia Biosciences Inc Company Information
- CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director
- Thomas J. Schaefer C.F.A.
- Headquarters
- 5956 Sherry Lane, Dallas, TX, United States, 75225
- Website
- arcadiabio.com
- Phone
- 214 974 8921
- IPO / Founded
- 2015-05-15
- Sector
- Consumer Defensive
- Industry
- Packaged Foods